Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 3/20 | 0.40 |
| ▸ | RBP4 | P02753 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MALT1 | Q9UDY8 | 7/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | PSD | A5PKW4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29416641 | 0.94 | DHODH (0.40) | DHODHRBP4MALT1 | |
| SCHEMBL121275 | 0.94 | DHODH (0.40) | DHODHRBP4MALT1 | |
| SCHEMBL12528140 | 0.92 | DHODH (0.39) | DHODHRBP4MALT1KMT2APSD | |
| SCHEMBL10028783 | 0.90 | DHODH (0.41) | DHODHRBP4MALT1KMT2AMEN1 | |
| SCHEMBL123506 | 0.89 | DHODH (0.40) | DHODHRBP4MALT1KMT2AMEN1 | |
| SCHEMBL29458550 | 0.89 | DHODH (0.40) | DHODHRBP4MALT1KMT2AMEN1 | |
| SCHEMBL29360347 | 0.89 | DHODH (0.40) | DHODHRBP4MALT1KMT2AMEN1 | |
| SCHEMBL950260 | 0.89 | DHODH (0.41) | DHODHRBP4MALT1KMT2APSD | |
| SCHEMBL13072493 | 0.88 | DHODH (0.43) | DHODHRBP4 | |
| SCHEMBL13072495 | 0.88 | DHODH (0.40) | DHODHRBP4MALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100137314-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20100099692-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-22 | — | — | US | disclosed |
| US-20100099692-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099692-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | UQCRC1, UQCRC2, Q6ZSR9 | DHODH 277/4885RBP4 1463/4885POLB 364/4885 |
| US-20100137314-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | UQCRC2, UQCRC1, UQCRB | DHODH 558/4885RBP4 1490/4885POLB 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.